Skip to main content
Erschienen in: Journal of Neurology 2/2013

01.02.2013 | Original Communication

Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009

verfasst von: Maura Pugliatti, Leslie D. Parish, Paola Cossu, Stefania Leoni, Anna Ticca, M. Valeria Saddi, Enzo Ortu, Sebastiano Traccis, Giuseppe Borghero, Roberta Puddu, Adriano Chiò, Pietro Pirina

Erschienen in: Journal of Neurology | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Recent genetic studies suggest a Sardinian type of amyotrophic lateral sclerosis (ALS). Thus, ALS incidence, prevalence and survival were investigated in a large population of Sardinians aimed to disclose population-specific patterns and their temporal changes. This is a population-based incidence and prevalence study in northern and central Sardinia, insular Italy (over 700,000 population). Incidence rates were computed for the time interval 1995–2009 and by quinquennia. Prevalence was computed for prevalence days 31 December 2004 and 2009. Onset-based survival for 1995–2009 is also reported. All ALS patients (El Escorial Criteria) in the study area were retrospectively included. The ALS crude incidence from 2005–2009 was 2.5 (95 % CIs: 0.1, 4.9), 3.4 in men and 1.6 in women. Onset occurred most often between the age of 65–74 years in men and 55–64 years in women. The ALS incidence tended to increase over the period 1995–2009. The mean age at onset was 61.7 years with no difference based on gender, varying significantly from 59.9 years in 1995–1999 to 63.9 years in 2005–2009. On December 31, 2009, the ALS crude prevalence was 10.8 per 100,000 (95 % CIs: 8.6, 13.1), 13.8 in men and 8.0 in women, whereas it was 6.3 per 100,000 (95 % CIs: 4.1, 8.6) on December 31, 2004 (M:F ratio of 0.95). Mean survival from onset was 37.0 months, with no difference based on gender, and a tendency to decrease during the period 1995–2009, in relation to type and age of onset. The population-based incidence and prevalence data of ALS in Sardinians indicate an increase of the disease occurrence over the past 40 years, providing support for a population-specific variant of ALS in Sardinia.
Literatur
1.
2.
Zurück zum Zitat Chiò A, Borghero G, Pugliatti M et al (2011) Large proportion of amyotrophic lateral sclerosis cases in sardinia due to a single founder mutation of the TARDBP gene. Arch Neurol 68:594–598PubMedCrossRef Chiò A, Borghero G, Pugliatti M et al (2011) Large proportion of amyotrophic lateral sclerosis cases in sardinia due to a single founder mutation of the TARDBP gene. Arch Neurol 68:594–598PubMedCrossRef
3.
Zurück zum Zitat Smith BN, Newhouse S, Shatunov A et al (2012) The C9ORF72 expansion mutation is a common cause of ALS+/− FTD in Europe and has a single founder. Eur J Hum Genet. doi:10.1038/ejhg.2012.98 Smith BN, Newhouse S, Shatunov A et al (2012) The C9ORF72 expansion mutation is a common cause of ALS+/− FTD in Europe and has a single founder. Eur J Hum Genet. doi:10.​1038/​ejhg.​2012.​98
4.
Zurück zum Zitat DeJesus-Hernandez M, Mackenzie IR, Boeve BF et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245–256PubMedCrossRef DeJesus-Hernandez M, Mackenzie IR, Boeve BF et al (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72:245–256PubMedCrossRef
5.
Zurück zum Zitat Renton AE, Majounie E, Waite A et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257–268PubMedCrossRef Renton AE, Majounie E, Waite A et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72:257–268PubMedCrossRef
6.
Zurück zum Zitat Majounie E, Renton AE, Mok K et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11:323–330PubMedCrossRef Majounie E, Renton AE, Mok K et al (2012) Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol 11:323–330PubMedCrossRef
7.
Zurück zum Zitat Chiò A, Restagno G, Brunetti M et al (2012) ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations. J Neurol Neurosurg Psychiatry 83:730–733PubMedCrossRef Chiò A, Restagno G, Brunetti M et al (2012) ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations. J Neurol Neurosurg Psychiatry 83:730–733PubMedCrossRef
9.
Zurück zum Zitat Logroscino G, Traynor BJ, Hardiman OH et al (2010) Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 81:385–390PubMedCrossRef Logroscino G, Traynor BJ, Hardiman OH et al (2010) Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry 81:385–390PubMedCrossRef
10.
Zurück zum Zitat Karvonen M, Tuomilehto J, Libman I, LaPorte R (1993) A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia 36:883–892PubMedCrossRef Karvonen M, Tuomilehto J, Libman I, LaPorte R (1993) A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. World Health Organization DIAMOND Project Group. Diabetologia 36:883–892PubMedCrossRef
11.
Zurück zum Zitat Loudianos G, Dessi V, Lovicu M et al (1999) Molecular characterization of wilson disease in the Sardinian population—evidence of a founder effect. Hum Mutat 14:294–303PubMedCrossRef Loudianos G, Dessi V, Lovicu M et al (1999) Molecular characterization of wilson disease in the Sardinian population—evidence of a founder effect. Hum Mutat 14:294–303PubMedCrossRef
12.
Zurück zum Zitat Pugliatti M, Solinas G, Sotgiu S, Castiglia P, Rosati G (2002) Multiple sclerosis distribution in northern Sardinia: spatial cluster analysis of prevalence. Neurology 58:277–282PubMedCrossRef Pugliatti M, Solinas G, Sotgiu S, Castiglia P, Rosati G (2002) Multiple sclerosis distribution in northern Sardinia: spatial cluster analysis of prevalence. Neurology 58:277–282PubMedCrossRef
13.
Zurück zum Zitat Marrosu MG, Lai M, Cocco E et al (2002) Genetic factors and the founder effect explain familial MS in Sardinia. Neurology 58:283–288PubMedCrossRef Marrosu MG, Lai M, Cocco E et al (2002) Genetic factors and the founder effect explain familial MS in Sardinia. Neurology 58:283–288PubMedCrossRef
14.
Zurück zum Zitat Pugliatti M, Cossu P, Sotgiu S, Rosati G, Riise T (2009) Clustering of multiple sclerosis, age of onset and gender in Sardinia. Neurol Sci 286:6–13CrossRef Pugliatti M, Cossu P, Sotgiu S, Rosati G, Riise T (2009) Clustering of multiple sclerosis, age of onset and gender in Sardinia. Neurol Sci 286:6–13CrossRef
15.
Zurück zum Zitat Piazza A, Mayr WR, Contu L et al (1985) Genetic and population structure of four Sardinian villages. Ann Hum Genet 49:47–63PubMedCrossRef Piazza A, Mayr WR, Contu L et al (1985) Genetic and population structure of four Sardinian villages. Ann Hum Genet 49:47–63PubMedCrossRef
16.
Zurück zum Zitat Cavalli-Sforza LL, Piazza A, Menozzi P, Mountain J (1988) Reconstruction of human evolution: bringing together genetic, archaeological, and linguistic data. Proc Natl Acad Sci USA 85:6002–6006PubMedCrossRef Cavalli-Sforza LL, Piazza A, Menozzi P, Mountain J (1988) Reconstruction of human evolution: bringing together genetic, archaeological, and linguistic data. Proc Natl Acad Sci USA 85:6002–6006PubMedCrossRef
17.
Zurück zum Zitat Underhill PA, Shen P, Lin AA et al (2000) Y chromosome sequence variation and the history of human populations. Nat Genet 26:358–361PubMedCrossRef Underhill PA, Shen P, Lin AA et al (2000) Y chromosome sequence variation and the history of human populations. Nat Genet 26:358–361PubMedCrossRef
18.
Zurück zum Zitat Brooks BR (1994) El Escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. subcommittee on motor neuron diseases/amyotrophic lateral sclerosis of the world federation of neurology research group on neuromuscular diseases and the El Escorial “clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 124(Suppl):96–107PubMedCrossRef Brooks BR (1994) El Escorial world federation of neurology criteria for the diagnosis of amyotrophic lateral sclerosis. subcommittee on motor neuron diseases/amyotrophic lateral sclerosis of the world federation of neurology research group on neuromuscular diseases and the El Escorial “clinical limits of amyotrophic lateral sclerosis” workshop contributors. J Neurol Sci 124(Suppl):96–107PubMedCrossRef
19.
Zurück zum Zitat Brooks BR, Miller R, Swash M, Munsat T (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 1:293–299CrossRef Brooks BR, Miller R, Swash M, Munsat T (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 1:293–299CrossRef
20.
Zurück zum Zitat Logroscino G, Traynor BJ, Hardiman OH et al (2008) Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatr 79:6–11PubMedCrossRef Logroscino G, Traynor BJ, Hardiman OH et al (2008) Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatr 79:6–11PubMedCrossRef
21.
Zurück zum Zitat Kobayashi Z, Tsuchiya K, Arai T et al (2010) Pseudopolyneuritic form of ALS revisited: Clinical and pathological heterogeneity. Neuropathology 30:372–380PubMedCrossRef Kobayashi Z, Tsuchiya K, Arai T et al (2010) Pseudopolyneuritic form of ALS revisited: Clinical and pathological heterogeneity. Neuropathology 30:372–380PubMedCrossRef
23.
Zurück zum Zitat Kurtzke JF (1997) The epidemiology of multiple sclerosis. In: Raine CS, McFarland HF, Tourtellotte WW (eds) Multiple sclerosis: clinical and pathogenetic basis. Chapman and Hall Medical, London, pp 91–139 Kurtzke JF (1997) The epidemiology of multiple sclerosis. In: Raine CS, McFarland HF, Tourtellotte WW (eds) Multiple sclerosis: clinical and pathogenetic basis. Chapman and Hall Medical, London, pp 91–139
24.
Zurück zum Zitat Rosati G, Pinna L, Granieri E et al (1977) Studies on epidemiological, clinical and etiological aspects of ALS disease in Sardinia Southern Italy. Acta Neurol Scand 55:231–244PubMedCrossRef Rosati G, Pinna L, Granieri E et al (1977) Studies on epidemiological, clinical and etiological aspects of ALS disease in Sardinia Southern Italy. Acta Neurol Scand 55:231–244PubMedCrossRef
25.
Zurück zum Zitat Giagheddu M, Puggioni G, Masala C et al (1983) Epidemiologic study of amyotrophic lateral sclerosis in Sardinia Italy. Acta Neurol Scand 68:394–404PubMedCrossRef Giagheddu M, Puggioni G, Masala C et al (1983) Epidemiologic study of amyotrophic lateral sclerosis in Sardinia Italy. Acta Neurol Scand 68:394–404PubMedCrossRef
26.
Zurück zum Zitat Giagheddu M, Mascia V, Cannas A et al (1993) Amyotrophic lateral sclerosis in Sardinia, Italy: an epidemiologic study. Acta Neurol Scand 87:446–454PubMedCrossRef Giagheddu M, Mascia V, Cannas A et al (1993) Amyotrophic lateral sclerosis in Sardinia, Italy: an epidemiologic study. Acta Neurol Scand 87:446–454PubMedCrossRef
27.
Zurück zum Zitat Chiò A, Mora G, Calvo A et al (2009) Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 72:725–731PubMedCrossRef Chiò A, Mora G, Calvo A et al (2009) Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology 72:725–731PubMedCrossRef
28.
29.
Zurück zum Zitat Durrleman S, Alperovitch A (1989) Increasing trend of ALS in France and elsewhere: are the changes real? Neurology 39:768–773PubMedCrossRef Durrleman S, Alperovitch A (1989) Increasing trend of ALS in France and elsewhere: are the changes real? Neurology 39:768–773PubMedCrossRef
30.
Zurück zum Zitat Chiò A, Magnani C, Schiffer D (1993) Amyotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study. Neurology 43:927–930PubMedCrossRef Chiò A, Magnani C, Schiffer D (1993) Amyotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study. Neurology 43:927–930PubMedCrossRef
31.
Zurück zum Zitat Beghi E, Logroscino G, Chiò A et al (2006) The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta 1762:1150–1157PubMedCrossRef Beghi E, Logroscino G, Chiò A et al (2006) The epidemiology of ALS and the role of population-based registries. Biochim Biophys Acta 1762:1150–1157PubMedCrossRef
32.
Zurück zum Zitat Cima V, Logroscino G, D’Ascenzo C et al (2009) Epidemiology of ALS in Padova district, Italy, from 1992 to 2005. Eur J Neurol 16:920–924PubMedCrossRef Cima V, Logroscino G, D’Ascenzo C et al (2009) Epidemiology of ALS in Padova district, Italy, from 1992 to 2005. Eur J Neurol 16:920–924PubMedCrossRef
33.
Zurück zum Zitat Imam I, Ball S, Wright D, Hanemann CO, Zajicek J (2010) The epidemiology of motor neurone disease in two counties in the southwest of England. J Neurol 257:977–981PubMedCrossRef Imam I, Ball S, Wright D, Hanemann CO, Zajicek J (2010) The epidemiology of motor neurone disease in two counties in the southwest of England. J Neurol 257:977–981PubMedCrossRef
34.
Zurück zum Zitat Román GC (1996) Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. J Neurol Neurosurg Psychiatr 61:131–137PubMedCrossRef Román GC (1996) Neuroepidemiology of amyotrophic lateral sclerosis: clues to aetiology and pathogenesis. J Neurol Neurosurg Psychiatr 61:131–137PubMedCrossRef
35.
Zurück zum Zitat Wijesekera LC, Mathers S, Talman P et al (2009) Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 72:1087–1094PubMedCrossRef Wijesekera LC, Mathers S, Talman P et al (2009) Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 72:1087–1094PubMedCrossRef
36.
Zurück zum Zitat Leone M, Chiò A, Mortara P et al (1983) Motor neuron disease in the Province of Turin, Italy, 1971–1980. Acta Neurol Scand 68:316–327PubMedCrossRef Leone M, Chiò A, Mortara P et al (1983) Motor neuron disease in the Province of Turin, Italy, 1971–1980. Acta Neurol Scand 68:316–327PubMedCrossRef
37.
Zurück zum Zitat Scott KM, Abhinav K, Wijesekera L et al (2010) The association between ALS and population density: A population based study. Amyotroph Lateral Scler 11:435–438PubMedCrossRef Scott KM, Abhinav K, Wijesekera L et al (2010) The association between ALS and population density: A population based study. Amyotroph Lateral Scler 11:435–438PubMedCrossRef
39.
Zurück zum Zitat Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ (2002) Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 59:280–282PubMedCrossRef Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ (2002) Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998. Neurology 59:280–282PubMedCrossRef
40.
Zurück zum Zitat Del Aguila M, Longstreth WT Jr, McGuire V, Koepsell TD, Van Belle G (2003) Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60:813PubMedCrossRef Del Aguila M, Longstreth WT Jr, McGuire V, Koepsell TD, Van Belle G (2003) Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 60:813PubMedCrossRef
41.
Zurück zum Zitat Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OH (2000) Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. Arch Neurol 57:1171–1176PubMedCrossRef Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OH (2000) Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. Arch Neurol 57:1171–1176PubMedCrossRef
42.
Zurück zum Zitat Chiò A, Mutani R, Mora G (2003) Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 61:1826–1827 (author reply 1827)PubMedCrossRef Chiò A, Mutani R, Mora G (2003) Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology 61:1826–1827 (author reply 1827)PubMedCrossRef
43.
Zurück zum Zitat Wolfson C, Kilborn S, Oskoui M, Genge A (2009) Incidence and prevalence of amyotrophic lateral sclerosis in Canada: a systematic review of the literature. Neuroepidemiology 33:79–88PubMedCrossRef Wolfson C, Kilborn S, Oskoui M, Genge A (2009) Incidence and prevalence of amyotrophic lateral sclerosis in Canada: a systematic review of the literature. Neuroepidemiology 33:79–88PubMedCrossRef
Metadaten
Titel
Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009
verfasst von
Maura Pugliatti
Leslie D. Parish
Paola Cossu
Stefania Leoni
Anna Ticca
M. Valeria Saddi
Enzo Ortu
Sebastiano Traccis
Giuseppe Borghero
Roberta Puddu
Adriano Chiò
Pietro Pirina
Publikationsdatum
01.02.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 2/2013
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6681-5

Weitere Artikel der Ausgabe 2/2013

Journal of Neurology 2/2013 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.